< Back to search
Filter
1
Active & Responsive

Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis

for
Multiple Sclerosis,
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18 - 70

Code: NCT07225361

Recruiting

A Single-Center Study to Characterize the Safety and Efficacy of Ublituximab in Older Adults With Relapsing Forms of Multiple Sclerosis (RMS)

for
Multiple Sclerosis, Relapsing Forms of Multiple Sclerosis
Location: Foxboro MA
Sponsor: Neurology Center of New England P.C.

Sex: All

Age: 55 - 70+

Code: NCT06681623

Recruiting

A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis

for
Multiple Sclerosis, Multiple Sclerosis, Primary Progressive,
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 18 - 65

Code: NCT06138132

Phase1, Recruiting

Interested in new relapsing forms of multiple sclerosis trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image